Main > > >CARDIOMYOPATHY. *

---

Cardio.>CardioMyopathy. Treat.: Tafami- dis/Tafamidis Meglumine.
Familial Amyloid CardioMyopathy.
Wild-Type or Hereditary Transthyretin-Mediated Amyloidosis (ATTR-CM) in Adults
EU Approval Date : 2020. 02.18.
JP Approval Date : 2019. 03.
USA Approval Date: 2019. 05.06.
(*) Company; Patents; TradeMarks & Web-
Site Available on Request.
UpDate: 2020. 02.20.




Incidence Reduction: Dexrazoxane.HCl Inj. Brand.
(Associated with Doxorubicin Administra- tion in Women with Metastatic Breast Cancer)
USA Approval Date: 1995. 05.26.
(*) Company : Pfizer.
Patent : Expired.
TradeMark: Zinecard
UpDate: 2019. 03.20.


>CARDIOMYOPATHY. *'s products
This section has no products